Andrea Charles | 08/17/2011
Dr. Barbara J. Potts, Senior Consultant, Potts and Nelson Consulting, joins Andrea Charles from Pharma, IQ to discuss the biggest threats to the safety of biologics and which contaminants present the most problems. Potts also shares her insights on common myths surrounding mycoplasma and why they persist, developments in PCR kits and how to ensure the safety of raw materials.
To continue reading this story Click Here
RECOMMENDED
Digital Transformation in Pharma: Navigating CMO Partnerships and Supply Chain Resilience
2025-01-22
Upcoming Events
Pharma Contract Manufacturing
23 - 25 March 2026
Mercure Hotel MOA Berlin, Germany
Register Now |
View Agenda |
Learn More